Several studies have demonstrated that MCL-1 and Bcl-2 are overexpressed frequently in AML cell lines, with high expression levels being associated with poor prognoses and resistance to chemotherapy (Delia et al., 1992; Fowler-Shorten et al., 2024). The gene discussed is BCL2; the disease is acute myeloid leukemia.